__MAIN_TEXT__

Page 1

EuroValve October 24-25 2014 Roma Eventi Fontana di Trevi

Rome, Italy

www.eurovalvecongress.com

Course directors: Patrizio Lancellotti, Liege, Belgium Khalil Fattouch, Palermo, Italy Gilbert Habib, Marseille, France JosĂŠ Luis Zamorano, Madrid, Spain


Edito Welcome to EuroValve 2014! It is a great pleasure to welcome you for this second edition in the beautiful city of Rome, which offers something for everyone: whether you are a culture or art passionate, an Italian cuisine lover, a fashion addict, The Romantic City is sure to please you. As you may know, this year we will favor more interactivity and discussions, especially thanks to several symposia and controversies. Again, over 2 days, we will present an extensive program dedicated to valvular heart disease, focusing on genetics, surgery, epidemiology, transcatheter valve replacement, echocardiography, new imaging. New this year, we are hosting an ePoster competition with outstanding scientific works from selected abstracts received, that you will have the opportunity to view on the interactive screens onsite on the exhibition hall. Take your time to visit the exhibition and discover the Industry news as it is only thanks to their precious help that we could achieve our ambitious program and do not miss Abbott symposium on Friday and Sorin symposium on Saturday in the plenary room. We are very pleased to have you during two convivial days of fruitful teaching in the eternal city. Enjoy the congress! The EuroValve Directors Patrizo Lancellotti, Khalil Fattouch, Gilbert Habib and José Luis Zamorano

Scientific Program Committee Ottavio Alfieri, Milan, Italy Bernard Iung, Paris, France Philippe Kolh, Liege, Belgium Giovanni La Canna, Milan, Italy Gerald Maurer, Vienna, Austria Luc Piérard, Liege, Belgium Bernard Prendergast, Oxford, United Kingdom Raphael Rosenhek, Vienna, Austria Giuseppe Speziale, Bari, Italy Christophe Tribouilloy, Amiens, France

Faculty Jutta Bergler-Klein, Vienna, Austria Paolo Colonna, Rome, Italy Bernard Cosyns, Braine-L’Alleud, Belgium Victoria Delgado, Leiden, The Netherlands Mauro Del Giglio, Cotignola, Italy Alessandro Della Corte, Naples, Italy Erwan Donal, Rennes, France Raluca Dulgheru, Brussels, Belgium Giovanni Esposito, Naples, Italy Arturo Evangelista, Barcelona, Spain Maurizio Galderisi, Naples, Italy Alexandra Gonçalves, Boston, USA

Julien Magne, Limoges, France Thomas Modine, Lille, France Jean-Luc Monin, Créteil, France Giuseppe Nasso Cécile Oury, Liege, Belgium Agnes Pasquet, Brussels, Belgium Philippe Pibarot, Quebec, Canada Prakash Punjabi, London, United-Kingdom Martin J. Swaans, Nieuwegein, The Netherlands Pilar Tornos, Barcelonna, Spain Philippe Unger, Brussels, Belgium

Eucomed Code of Ethical Business Practice: COMPLIANT


EuroValve

Synoptic

October 24-25 2014, Rome, Italy

www.eurovalvecongress.com

FRIDAY OCTOBER 24 08:30 Opening ceremony Patrizio Lancellotti, Khalil Fattouch, Gilbert Habib, José Luis Zamorano

SATURDAY OCTOBER 25 08:30 Symposium: the mystery of tricuspid valve Ottavio Alfieri, Philippe Unger

08:45 Symposium: measuring the risk in valve patients Bernard Prendergast, Luc Piérard (Joint with ESC WG Valve Disease)

09:30 Keynote lecture J. Bergler-Klein, B. Cosyns 09:45 Keynote lecture J. L. Zamorano, G. Habib 09:45 Coffee break in the exhibition hall 10:05 Coffee break in the exhibition hall 10:15 Symposium: rhythm and mechanical activation 10:30 Symposium: controls in VHD challenges for the clinical cardiologists. Jose Luis Zamorano Is Echo-Imaging helpful? Gerald Maurer, Victoria Delgado (Joint with the EACVI)

11:30

Surgical talk on demand: focus on minimally invasive approach G. Speziale

11:30

Symposium Patients Live Innovation

12:30

Lunch break in the exhibition hall

12:00 Symposium Your future with MitraClip

José Luis Zamorano, Raphael Rosenhek

13:00 Lunch break in the exhibition hall 13:30 Clinical session: challenging clinical situation 14:00 Symposium: diagnostic and treatment of patients with aortic regurgitation

Gerald Maurer, Khalil Fattouch

Paolo Colonna, Arturo Evangelista

15:00 Clinical session: challenging the guidelines 15:30 Keynote lecture

Philippe Kolh, Patrizio Lancellotti

Erwan Donal, Giovanni La Canna

16:00 Coffee break in the exhibition hall 16:30 Controversies in VHD Bernard Iung, Pilar Tornos

16:30 Closing remarks / ePosters awards ceremony Patrizio Lancellotti, Khalil Fattouch, Gilbert Habib, José Luis Zamorano

17:30 Controversy: when to operate in infective endocarditis? Ottavio Alfieri

18:30 End of the sessions

www.eurovalvecongress.com


Friday October 24, 2014 08:30

Opening ceremony Patrizio Lancellotti, Khalil Fattouch, Gilbert Habib, José Luis Zamorano

08:45

Symposium: measuring the risk in valve patients

08:45 08:58 09:11 09:24

Bernard Prendergast, Luc Piérard (Joined with ESC WG Valve Disease) • EuroScore II and STS score: are they similar? Julien Magne • Lessons learnt from the TAVI story? Bernard Iung • How to evaluate the risk in elderly subjects? Raphael Rosenhek • An illustrative case, Patrizio Lancellotti • Round table discussion

09:45

Keynote lecture

09:45

José Luis Zamorano, Gilbert Habib • Controversies in tricuspid regurgitation: risk marker? Patrizio Lancellotti

10:05

Coffee break in the exhibition hall

10:30 Symposium: challenges for the clinical cardiologists. Is Echo-Imaging helpful? Gerald Maurer, Victoria Delgado (Joined with the EACVI) 10:30 10:45 11:00

Focus on aortic valve Clinical case: a 70-years old attorney with severe aortic stenosis, impaired LV systolic function and mitral regurgitation • Severe or not? Philippe Pibarot • When to operate? Christophe Tribouilloy • Should we repair/replace the mitral valve? Maurizio Galderisi

11:30

Surgical talk on demand: focus on minimally invasive approach

11:30 11:40

Giuseppe Speziale, Martin J. Swaans • Does minimally invasive mitral valve repair compromise the results? Khalil Fattouch • Mininvasive mitral valve repair live cases (Anthea Hospital, Bari, Italy) Surgeon: Giuseppe Nasso • Does minimally invasive aortic replacement reduce risk of surgery? Mauro del Giglio

11:50

12:00

Symposium Your future with MitraClip, José Luis Zamorano, Raphael Rosenhek

MDT panel: Dabit Arzamendi, Victoria Delgado, Ottavio Alfieri, Raphael Rosenhek 12:00 • Introduction, Raphael Rosenhek 12:03 • Mitral Regurgitation: how big is the problem? José Luis Zamorano 12:15 • Who is the right MitraClip patient? Victoria Delgado 12:27 • When to refer for MitraClip? Ottavio Alfieri 12:39 • Why and how to start with MitraClip? Dabit Arzamendi • MDT Q&A 12:52 • Take home, Raphael Rosenhek 13:00 Lunch break in the exhibition hall


14:00

Symposium: diagnostic and treatment of patients with aortic regurgitation

14:00 14:18 14:36 14:54 15:12

Gilbert Habib, Patrizio Lancellotti • Pathophysiology of aortic regurgitation, Pilar Tornos • What are the best diagnostic tools to quantify aortic regurgitation? Agnes Pasquet • How should patients with AR be followed-up and when is the best time to operate? Raphael Rosenhek • State of the art aortic valve/root surgery for AR, Alessandro Della Corte • Is there a place for transcatheter valve implantation? Giovanni Esposito

15:30

Keynote lecture

15:30

Erwan Donal, Giovanni La Canna TAVI: worldwide experience and new trends, Thomas Modine

16:00

Coffee break in the exhibition hall

16:30 Controversies in VHD Bernard Iung, Pilar Tornos 16:30

• Paravalvular regurgitation, even mild, is a risk factor for mortality following TAVI, Jean-Luc Monin 17:00 • Mild paravalvular regurgitation is not an independent predictor of mortality following TAVI, Philippe Pibarot

17:30 Controversy: when to operate in infective endocarditis? Ottavio Alfieri 17:30 18:00

• Earlier is the must? Gilbert Habib • Always later? Bernard Prendergast

18:30

End of the sessions


Saturday October 25, 2014 08:30

Symposium: the mystery of tricuspid valve

08:30 08:45 09:00 09:15

Ottavio Alfieri, Philippe Unger • Functional anatomy of the tricuspid valve and right ventricle, Khalil Fattouch • Imaging assessment, Jose Luis Zamorano • When to operate? Luc Piérard • Surgical techniques and outcomes, Prakash Pubjabi • Round table discussion

09:30

Keynote lecture

09:30

Jutta Bergler-Klein, Bernard Cosyns • Emerging biomarkers in VHD, Cécile Oury

09:45

Coffee break in the exhibition hall

10:15

Symposium: rhythm and mechanical activation controls in VHD

10:15 10:33 10:51 11:09

Jose Luis Zamorano • AF in VHD: a turning point in the natural history, Erwan Donal • Surgical ablation of AF in VHD, Philippe Kolh • MitraClip and CRT in mitral regurgitation: a good marriage? Victoria Delgado • Dyssynchrony in aortic stenosis and no flow reserve: a reality? Raluca Dulgheru

11:30 Symposium Patients Live Innovation

Sorin solutions for aortic and Mitral procedures Borut Gersak, Patrizio Lancellotti • Aortic Valve in Valve Implantation in the Mitroflow Bioprosthetic Valve: a review of current literature, Brian Bethea • Native-like performance: the Solo Smart experience, Herko Grubitzsch • Improving patient outcome in AVR: the Perceval experience, Sergio Canovas • Outcomes after restrictive annuloplasty in IMR: clinical impact of different rings, Khalil Fattouch

12:30

Lunch break in the exhibition hall

13:30

Clinical session: challenging clinical situation

13:30 13:52 14:14 14:36

Gerald Maurer, Khalil Fattouch • A patient with multiple valve disease, Philippe Unger • A young patient with aortic valve endocarditis, Gilbert Habib • A patient with angina and moderate aortic stenosis, Alexandra Gonçalves • A patient with VHD and desire for pregnancy, Bernard Iung

15:00

Clinical session: challenging the guidelines

15:00 15:22 15:44 16:06

Philippe Kolh, Patrizio Lancellotti • Mitral regurgitation, Giovanni La Canna • Aortic stenosis, Julien Magne • Aortic regurgitation, Victoria Delgado • Marfan disease, Arturo Evangelista

16:30

Closing remarks / ePosters awards ceremony

Patrizio Lancellotti, Khalil Fattouch, Gilbert Habib, José Luis Zamorano


ePosters competition • Implantation of an Edwards Intuity rapid deployement aortic valve: one year single center Experience, Gian Luca Martinelli, Maurizio Braccio, Attilio Cotroneo, Rossella Alemanni, Rosamaria Montesanti, Mauro Cassese •O  utcome of patients with low-flow aortic stenosis with preserved ejection fraction. Are there differences according to the echocardiographic parameters? Nuria Vallejo Camazon, Gladys Junca, Elena Ferrer, Francisco Gual, Jorge Lopez Ayerbe, Albert Teis, Antoni Bayes Genis •E  ndocarditis in octogenarians. Less surgery and higher mortality in our area nowadays? Gladys Junca, Nuria Vallejo Camazon, Elena Ferrer, Jorge Lopez Ayerbe, Albert Teis, Raquel Pla, Carlos Diez, Francisco Gual, Antoni Bayes Genis • Impact of patient prosthesis mismatch on left ventricular filling pressure increase after transcatheter aortic valve implantation, Galderisi Maurizio, Marco Fabio Costantino, Ciro Santoro, Giandomenico Tarsia, Pasquale Innelli, Ernesta Dores, Antonella Matera, Giovanni Esposito, Giovanni de Simone, Bruno Trimarco •C  linical significance of serial BNP changes in asymptomatic patients with aortic stenosis, Christine Henri, Raluca Dulgheru, Julien Magne, Luis Caballero, Saloua Laaraibi, Seisyou Kou, Damien Voilliot, Laurent Davin, Luc Pierard, Patrizio Lancellotti •R  elationship between left atrial deformation and B-type natriuretic peptide activation in asymptomatic aortic stenosis, Christine Henri, Raluca Dulgheru, Julien Magne, Seisyou Kou, Laurent Davin, Alain Nchimi, Cecile Oury, Luc Pierard, Patrizio Lancellotti •L  eft ventricular longitudinal deformation and B-type natriuretic peptide activation and changes in asymptomatic aortic stenosis, Christine Henri, Raluca Dulgheru, Julien Magne, Seisyou Kou, Laurent Davin, Alain Nchimi, Cecile Oury, Luc Pierard, Patrizio Lancellotti •D  ouble orifice mitral valve, Amina Elfhal, Ilham Bensahi, Maria Melissoupoulou, Elena Dulgheru, Luc Pierard, Patrizio Lancellotti •A  scending aortic elastic properties and LV longitudinal function in isolated bicuspid aortic valve by speckle tracking echocardiography, Fabio D’Aiello, Danila Avitabile, Giovanni Di Salvo, Ciro Bancone, Marianna Buonocore, Marco Montibello, Maria Giovanna Russo, Alessandro Della Corte •S  creening for valvular heart disease: anxiety and attitudes in the oxVALVE population cohort study, Joanna d’Arcy, Sean Coffey, Margaret Loudon, Louise Locock, Andrew Farmer, Bernard Prendergast •M  inimally invasive approach for aortic surgery in octogenarians, Luigi Specchia, Salvatore Nicolardi, Federica Mangia, Mattia Scognamiglio, Olivera Rasovic, Salvatore Foggetti, Salvatore Lentini, Renato Gregorini, Giuseppe Di Eusanio •Q  uadricuspid aortic valve associated with a genesis of circumflex coronary: a rare congenital cardiac entity, Ilham Bensahi, Amina Elfhal, Raluca Dulgheru, Christine Henri, Luc Pierard, Patrizio Lancellotti •L  eft ventricular mass regression early after sutureless implantation of the ATS 3F enable aortic valve bioprosthesis, Luca Salvatore De Santo, Stefano de Notaris, Emilio Mango, Leonardo Savarese, Francesco Iorio, Mario Miele, Flora Numis, Donato Catapano, Paola Tesorio, Sergio Maria Caparrotti •S  utureless 3F enable valve in valve implantation for tricuspid bioprosthesis degeneration, Stefano de Notaris, Luca Salvatore De Santo, Emilio Mango, Leonardo Savarese, Francesco Iorio, Mario Miele, Flora Numis, Donato Catapano, Paola Tesorio, Sergio Maria Caparrotti


ePosters competition •P  ercutaneous valve in valve treatment of degenerate tricuspid bio prosthesis by transfemoral route, Fausto Castriota, Flavio Ribichini, Mauro Del Giglio, Gabriele Pesarini, Corrado Vassanelli, Alberto Cremonesi •T  he impact of ethnicity on the prevalence and length of hospital stay in patients with aortic valve stenosis, Clare Thakker, Nicholas D Gollop, Paul Carter, Hardeep Uppal, Suresh Chandran, Rahul Potluri •R  isk stratification in severe aortic stenosis: the importance of ventriculo-arterial interplay, Elena Galli, Emmanuel Oger, Yvan Guirette, Vincent Auffret, Philippe Mabo, Erwan Donal •C  linical outcomes of aortic valve repair in asymptomatic patients with chronic severe aortic valve regurgitation, Egle Corrado, Benedetta La Fata, Emanuela Clara Bertolino, Patrizia Carità, Giuseppa Caccamo, Claudia Visconti, Sebastiano Castrovinci, Giacomo Murana, Antonio Rubino, Carmelo Mignosa, Marco Moscarelli, Prakash Punjabi, Khalil Fattouch •T  en years follow-up of Bicuspid Aortic Valve (BAV) Repair according to morphology, functional classification and surgical tecniques, Khalil Fattouch, Giacomo Murana, Sebastiano Castrovinci, Patrizia Carità, Emanuela Clara Bertolino, Giuseppa Caccamo, Egle Corrado, Pietro Dioguardi, Giuseppe Nasso, Giuseppe Speziale, Marco Moscarelli, Prakash Punjabi •S  hort-term clinical outcomes among patients undergoing transcatheter aortic valve implantation (TAVI) in a single centre, Armando Pucciarelli, Tullio Tesorio, Linda Cota, Angelo Cioppa, Gregory Popusoy, Eugenio Stabile, Luigi Salemme, Paolo Rubino •L  eft atrial systolic function impairment and prognosis in severe aortic stenosis, Elena Galli, Yvan Guirette, Vincent Auffret, Philippe Mabo, Erwan Donal •L  eft ventricular global longitudinal strain predicts post-operative left ventricular dysfunction in patients with primary mitral regurgitation, Elena Galli, Emmanuel Oger, Mayliss Levery, Philippe Mabo, Erwan Donal •A  ortic regurgitation after transcatheter valve implantation: subvalvular calcification as a predictor of paraprosthetic regurgitation, Angelo Squeri, Stefano Censi, Marco Baldelli, Chiara Grattoni, Fausto Castriota, Stefano Bosi, Alberto Cremonesi •P  revalence and determinants of right ventricular dysfunction in severe aortic stenosis, Elena Galli, Yvan Guirette, Vincent Auffret, Philippe Mabo, Erwan Donal •C  an left ventricular afterload influence rv function in aortic stenosis? Elena Galli, Yvan Guirette, Philippe Mabp, Erwan Donal •V  entriculo-arterial impedance differently impact 2D strain parameters in patients with aortic stenosis, Elena Galli, Yvan Guirette, Philippe Mabo, Erwan Donal •T  he impact of ethnicity on the prevalence and length of hospital stay in patients with mitral regurgitation, Syed Kazim Ali Shan, Joshim Khan, Fatemah Ziaei, Raj Bhayani, Savana Shakir, Hardeep Uppal, Suresh Chandran, Rahul Potluri •D  oes the preoperative left atrium size influence the outcome of surgical radiofrequency ablation in associated atrial fibrillation? Gheorghe Cerin, Bogdan Adrian Popa, Silvia Simonini, Levan Karazanishvili, Diana Benea, Anamaria Popa, Marco Diena, Romano Angelo


•E  arly and mid-term outcomes after aortic valve replacement with a sutureless prosthesis: single center experience, Carmelo Mignosa, Salvatore Di Stefano, Carlo Mariani, Antonella Romeo, Angelo Giuffrida, Roberta Adamo, Francesco Monaco, Wanda Deste, Antonino S. Rubino •T  ranscatheter aortic valve implantation (TAVI): assessment of myocardial systolic performance with 2D speckle tracking echocardiography, Silvia Picarelli, Elisabetta Amici, Carla Boschetti, Claudia Pandolfi, Rosario Fiorilli, Alberta Cifarelli, Roberto Francavilla, Roberto Violini, Giancarlo Gambelli •S  urgery of aortic root and ascending aorta through an upper ministernotomy: single centreexperience, Luigi Specchia, Salvatore Nicolardi, Federica Mangia, Mattia Scognamiglio, Olivera Rasovic, Salvatore Foggetti, Salvatore Lentini, Marcello Melone, Cristina Conti, Rebani Sinani, Renato Gregorini, Giuseppe Di Eusanio •C  ontractile properties of the right atrial myofilaments in patients with myxomatous mitral valve degeneration, Constanze Bening, Uwe Mehlhorn, Ahmad Abugameh, Daniela Link, Christian-Friedrich Vahl •B  ologna early-experience with the Trifecta pericardial aortic valve prosthesis, Luca Di Marco, S. Castrovinci, J. Alfonsi, G. Murana, A. Leone, D. Pacini, A. Loforte, R. Di Bartolomeo •S  upine exercise echocardiography irrelevant to assess exercise capacity, Olivia Domanski, Augustin Coisne, Marjorie Richardson, Anne-Sophie Polge, Anju Duva Pentiah, Stéphanie Mouton, Aida Ben Abda, David Montaigne •H  emodynamic and regurgitation after TAVI. An in vitro study, Salaun Erwan, Zenses Anne Sophie, Evin Morgane, Collart Frederic, Pibarot Philippe, Habib Gilbert, Rieu Regis •C  linical and echocardiographic outcomes at rest and under exercise after mitral valve annuloplasty for ischemic mitral regurgitation: impact of different rings, Francesco Guccione, Pietro Dioguardi, Egle Corrado, Patrizia Carità, Sebastiano Castrovinci, Giacomo Murana, Emerico Ballo, Giuseppe Bianco, Khalil Fattouch •P  ercutaneous mitral dilation; the alternative treatment to surgery, Farah Korchi, Ilham Bensahi, Amina Elfhal, Rachida Habbal •G  ender differences in patients with severe aortic stenosis: are women more “rigid”? M. Baroni, E. Cerone, E. Milano, M. Solinas, S. Berti, AM. Mazzone •A  logistic risk model predicts significant coronary artery disease in patients with degenerative aortic valve disease, Mazzone Annamaria, Murzi Michele, Baroni Monica, Miceli Antonio, Glauber Mattia, Solinas Marco, Berti Sergio, De Caterina Raffaele, Gilmanov Dyniar


Notes ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ...................................................................... ......................................................................


Discover more at www.Daiichi-Sankyo.EU

Today, through a growing presence in emerging markets we are pleased to meet the needs of patients in more than 50 countries around the world.

Building on our experience of innovation in the areas of cardiovascular diseases and bacterial infections, Daiichi Sankyo is expanding into other important therapeutic areas where significant unmet medical needs remain, such as the development of medicines for blood clot and stroke prevention, cancer treatments, and medicines for diabetes and related conditions.

Daiichi Sankyo is a global pharmaceutical company with a legacy of over 100 years of scientific expertise and its corporate origin in Japan.


Information Congress venue: Roma Eventi Fontana Di Trevi, Rome, ITALY Piazza Della Pilotta, 4 – 00187 Rome • Tel. +39 0667015176-77 • Fax: +39 0667015178 Nearby points of interest: Fontana di Trevi:150 m • Piazza Venezia: 400 m • Piazza di Spagna: 800 m • Quirinale: 300 m REGISTRATION DESK OPENING HOURS Friday October 24 Saturday October 25

07.30 - 19.00 08.00 - 17.00

EVENT COORDINATORS’CONTACTS Project Manager Stéphanie Meyer + 33 646 10 48 26 Managing director Vérane Bergeron Moreau + 33 621 78 87 16 Registration / Accommodation Michèle Caboste + 33 613 96 08 70

Stay alert Keep up to date with the highest quality material, both scientific and clinical, from all areas of cardiovascular imaging with email table of contents alerts from the European Heart Journal – Cardiovascular Imaging

At the heart of Cardiology Sign up under the ‘Alerting Services’ heading at: ehjcimaging.oxfordjournals.org


st

ina

Barberini

Qu

Vi

af

tro

o a

ia

G en ov a

os

tin

o

De

pr

et

is

a

ti

Na

zi

on

e al

Ag

Pa

er

en

Vi

ac

a Vi

Vi

a

a

G

rm

a M ila

ta

no

P il o t

Antico Palazzo Rospigliosi****

Vi

d e ll a

ag gi o Vi a XX IV M

V ia

Vi

Roma Eventi Fontana Di Trevi

Pi

Termini

iob

1

V

ia

Eurostars International Palace Hotel**** a z V

o

rto a

Q

e

rin

be Vi

l de

n

an

To

Um

Fontana di Trevi

ri ui

e al

nt

Via

or

Fo

Republica

ur

Tr

at

a

vo

lle

Se

Ca

de

XX

a

a

e

ta

ne

Vi

ll a

br

ae

ase V ia R

m tte

G

e le C a s

a

V ia

T r it o del

Si

Vi

Capo V ia d i

a

Vi

Vi

V ia

Pan

na is p e r Vi

a

P

l ao

in

a

Vi

a

Na

po

leo

ne

III

HOTEL LIST

Antico Palazzo Rospigliosi****

Eurostars International Palace Hotel****

Via Liberiana, 21 - 00185 Rome, Italy 10 min walking distance from Roma Eventi Fontana di Trevi

Via Nazionale, 46 - 00184 Rome, Italy 10 min walking distance from Roma Eventi Fontana di Trevi

Access: at a walking distance from the Termini Railway Station of Rome (150 meters). From Termini follow Via Cavour-Piazza Dell’Esquilino.

Access: at a walking distance from the Termini Railway Station of Rome (150 meters). From Termini follow Via Cavour-Piazza Dell’Esquilino.

www.eurovalvecongress.com


Fontana

Exhibition hall +0.64

+0.48 +0.64 +0.32 +0.48

+0.16

0.00

Plenary room -0.16

+0.48

-0.32

+0.32

+0.16 0.00 -0.16 -0.32

Buffet

Buffet

+1.41

0.00

-0.48

-0.32 -0.16 0.00 +0.16 +0.16 +0.32

-0.32

+0.48

B

-0.16 +0.64

2

1

0.00

+0.16

+0.32

B

Office

Preview

0.00

+0.48

+0.64

3

4

+0.64

Exhibition hall

Posters

7

Booth Company 1 2 3 4 5 6 7

Sorin group Esaote

ENTRANCE 1,89

Buffet

5

Buffet

6

Registration desk 2,04

Cloakroom

EXHIBITION TIMES Friday October 24 Saturday October 25

Philips Hitachi EACVI

Micardia GE Healthcare

ORGANIZATION divine [id] agency • Stéphanie Meyer: smeyer@divine-id.com Mob. +33 (0) 646 10 48 26 •V  érane Bergeron Moreau: vbergeron@divine-id.com • 17, rue Venture - 13001 Marseille, France • Tel. +33 (0) 491 57 19 60 • Fax +33 (0) 491 57 19 61 • www.divine-id.com

08.00 - 19.00 08.00 - 14.00


cardiac surgery solutions patients live innovation.

equipped to perform perceval

IM-00280 A

memo 3d

Heartlink

Š 2014 Sorin Group www.sorin.com info.cardiacsurgery@sorin.com

ETHICAL COLLABORATION IN HEALTHCARE

CERTIFIED

Licensed by Eucomed

TM


www.eurovalvecongress.com ACKNOWLEDGEMENTS 2014

Profile for divine [id]

EuroValve 2014 Program  

October 24-25 2014, Roma Eventi Fontana Di Trevi, ITALY All you need to know on Valvular heart disease - From genetics to surgery - From ep...

EuroValve 2014 Program  

October 24-25 2014, Roma Eventi Fontana Di Trevi, ITALY All you need to know on Valvular heart disease - From genetics to surgery - From ep...

Profile for divine-id
Advertisement